ImQuest Biosciences, based in Frederick, Maryland, is developing a skin patch to deliver antiretroviral medications, according to a presentation at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition being held October 23 through 27 in Washington, DC. Though the patch is in very early stages of development—it has not yet been studied in animals, let alone humans—it holds great promise for people living with HIV, the researchers suggest.
According to lead presenter Anthony Ham, PhD, of ImQuest, a single transdermal patch can be used to deliver seven days of medication into the bloodstream.
[...]
Complete article at Aids Med : http://bit.ly/vetLkx
